NEW YORK (GenomeWeb News) – SomaLogic has raised $10 million in equity financing, the company said in a document filed with the US Securities and Exchange Commission on Tuesday.

The Boulder, Colo.-based protein biomarker discovery and clinical diagnostics company declined to comment on the financing. In its Form D document, it said that it had one investor in the round but did not identify the investor. SomaLogic did not say how proceeds will be used.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.